Insights from medtech regulatory leaders

The 2025 Veeva MedTech Regulatory Affairs Benchmark reveals that many medtech companies lack confidence in their data’s completeness or accuracy and still rely heavily on manual processes to maintain compliance. 

55%

Indicate it would take significant time and effort to find where a product is registered globally

50%

Are only somewhat or not at all confident their data includes all relevant registration information

67%

Have partially or entirely manual processes for monitoring key metrics

Complete the form to download the full report for insights on the state of regulatory affairs and how medtech companies are working to prioritize automation, strengthen data governance, and adopt advanced technologies.

See data, insights, and recommendations concerning:

  • Identifying global product registrations
  • Manual vs. automated processes for metrics monitoring
  • Largest gaps in regulatory affairs teams
  • Regulatory data quality for AI implementation
  • Planned adoption of new tools and methodologies